1. Home
  2. SUPN vs SJW Comparison

SUPN vs SJW Comparison

Compare SUPN & SJW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • SJW
  • Stock Information
  • Founded
  • SUPN 2005
  • SJW 1866
  • Country
  • SUPN United States
  • SJW United States
  • Employees
  • SUPN N/A
  • SJW N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • SJW Water Supply
  • Sector
  • SUPN Health Care
  • SJW Utilities
  • Exchange
  • SUPN Nasdaq
  • SJW Nasdaq
  • Market Cap
  • SUPN 1.7B
  • SJW 1.9B
  • IPO Year
  • SUPN 2012
  • SJW N/A
  • Fundamental
  • Price
  • SUPN $31.70
  • SJW $53.32
  • Analyst Decision
  • SUPN Hold
  • SJW Strong Buy
  • Analyst Count
  • SUPN 2
  • SJW 3
  • Target Price
  • SUPN $36.00
  • SJW $58.00
  • AVG Volume (30 Days)
  • SUPN 420.5K
  • SJW 292.6K
  • Earning Date
  • SUPN 05-06-2025
  • SJW 04-28-2025
  • Dividend Yield
  • SUPN N/A
  • SJW 3.06%
  • EPS Growth
  • SUPN N/A
  • SJW 12.16
  • EPS
  • SUPN 1.11
  • SJW 2.98
  • Revenue
  • SUPN $667,997,000.00
  • SJW $766,656,000.00
  • Revenue This Year
  • SUPN N/A
  • SJW $4.56
  • Revenue Next Year
  • SUPN $9.14
  • SJW $4.70
  • P/E Ratio
  • SUPN $28.49
  • SJW $18.40
  • Revenue Growth
  • SUPN 11.82
  • SJW 12.34
  • 52 Week Low
  • SUPN $25.53
  • SJW $44.91
  • 52 Week High
  • SUPN $40.28
  • SJW $62.18
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 47.88
  • SJW 44.97
  • Support Level
  • SUPN $29.16
  • SJW $53.20
  • Resistance Level
  • SUPN $33.28
  • SJW $55.94
  • Average True Range (ATR)
  • SUPN 1.19
  • SJW 1.55
  • MACD
  • SUPN 0.02
  • SJW -0.17
  • Stochastic Oscillator
  • SUPN 61.65
  • SJW 12.70

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About SJW SJW Group (DE)

SJW Group is a U.S. water utility services holding company that provides, stores, purifies and distributes water. The company predominantly operates in various Californian municipalities and also has operations in other states. Its operating segments include Water Utility Services and Real Estate Services. The majority of the company's revenue is derived from its water utility services segment.

Share on Social Networks: